Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 4/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.38 |
| ▸ | EPAS1 | Q99814 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL623480 | 0.92 | ALOX15 (0.49) | ALOX15HIF1AEPAS1ALDH1A1TSHR | |
| SCHEMBL309378 | 0.91 | ALOX15 (0.42) | ALOX15HIF1AEPAS1ALDH1A1TSHR | |
| SCHEMBL874024 | 0.90 | ALOX15 (0.41) | ALOX15HIF1AEPAS1ALDH1A1TSHR | |
| SCHEMBL2787188 | 0.89 | TSHR (0.43) | ALOX15HIF1AEPAS1ALDH1A1TSHR | |
| SCHEMBL873163 | 0.89 | TSHR (0.43) | ALOX15HIF1AEPAS1ALDH1A1TSHR | |
| SCHEMBL28158330 | 0.89 | TSHR (0.43) | ALOX15HIF1AEPAS1ALDH1A1TSHR | |
| SCHEMBL29226615 | 0.88 | ALOX15 (0.35) | ALOX15HIF1AEPAS1 | |
| SCHEMBL1870227 | 0.88 | ALOX15 (0.47) | ALOX15HIF1AEPAS1ALDH1A1TSHR | |
| SCHEMBL538489 | 0.88 | ALOX15 (0.47) | ALOX15HIF1AEPAS1ALDH1A1TSHR | |
| SCHEMBL10584865 | 0.87 | ALOX15 (0.44) | ALOX15HIF1AEPAS1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1522 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260033519-A1 | STORAGE-STABLE BEVERAGES COMPRISING ANTHOCYANINS | BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIV (US) | 2026-02-05 | — | — | US | claimed |
| US-20250347684-A1 | METABOLIC BIOMARKERS IN BLOOD SERUM FOR DIAGNOSIS OF ALZHEIMER'S DISEASE | UNIV TEXAS (US) | 2025-11-13 | — | — | US | claimed |
| US-12404479-B2 | Laundry detergent composition containing graft copolymer and benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2025-09-02 | — | — | US | claimed |
| US-20250248400-A1 | NANOPARTICULATE FORMULATION FOR PREVENTING OR TREATING CALLOSE FORMATION IN PLANTS | PURDUE RESEARCH FOUNDATION (US) | 2025-08-07 | — | — | US | claimed |
| EP-4581114-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Novozymes A/S (DK) | 2025-07-09 | — | — | EP | claimed |
| US-20250176599-A1 | FLAVOR COMPOSITION AND FOOD AND BEVERAGE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2025-06-05 | — | — | US | claimed |
| EP-4555060-A1 | LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT | The Procter & Gamble Company (US) | 2025-05-21 | — | — | EP | claimed |
| WO-2025097045-A1 | COLLOIDAL FOOD BASE COMPOSITIONS COMPRISING MYCELIAL BIOMASS | THE FYNDER GROUP, INC (US) | 2025-05-08 | — | — | WO | claimed |
| US-12281070-B2 | Water soluble antiviral and antimicrobial compound and process for preparation thereof | DEB NILANJAN (IN) | 2025-04-22 | — | — | US | claimed |
| CN-119698458-A | Improvements in or relating to organic compounds improvements relating to organic compounds | 诺维信公司 | 2025-03-25 | — | — | CN | claimed |
| US-20050245430-A1 | Fragrance compositions comprising decamethyltetrasiloxane | L'OREAL (FR) | 2005-11-03 | — | — | US | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-6858217-B2 | Stabilization of terpenoids in cosmetic compositions | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) | 2005-02-22 | — | — | US | claimed |
| US-20030185867-A1 | Stabilization of terpenoids in cosmetic compositions | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-10-02 | — | — | US | claimed |
| WO-2003080011-A1 | STABILIZATION OF TERPENOIDS IN COSMETIC COMPOSITIONS | UNILEVER PLC (GB) | 2003-10-02 | — | — | WO | claimed |
| CN-1116396-C | Tiannu magnolia oil | LU JIANREN (CN) | 2003-07-30 | — | — | CN | claimed |
| CN-1289835-A | Tiannu Magnolia oil | LU JIANREN (CN) | 2001-04-04 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | ALOX15 868/4885HIF1A 1557/4885EPAS1 2500/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | ALOX15 797/4885HIF1A 1773/4885EPAS1 2350/4885 |
| US-20030185867-A1 | Stabilization of terpenoids in cosmetic compositions | SQLE, CYP51A1, RBP4 | ALOX15 102/4885HIF1A 2504/4885EPAS1 1491/4885 |
| US-20260033519-A1 | STORAGE-STABLE BEVERAGES COMPRISING ANTHOCYANINS | SIRT1, SIRT3, CRY1 | ALOX15 3096/4885HIF1A 3797/4885EPAS1 3657/4885 |
| US-12281070-B2 | Water soluble antiviral and antimicrobial compound and process for preparation thereof | ZC3HAV1, SAMHD1, ZC3HAV1L | ALOX15 2652/4885HIF1A 1115/4885EPAS1 2055/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.